Catherine Kim1, Carrie Karvonen-Gutierrez2, Shengchun Kong3, Valerie Arends4, Michael Steffes4, Daniel S McConnell2, John F Randolph5, Siobán D Harlow2. 1. Department of Medicine, University of Michigan, Ann Arbor, Michigan. Electronic address: cathkim@umich.edu. 2. Department of Epidemiology, University of Michigan, Ann Arbor, Michigan. 3. Gilead Sciences, Foster City, California. 4. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota. 5. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan.
Abstract
OBJECTIVE: To compare concentrations of antimüllerian hormone (AMH) in women with and without type 1 diabetes. DESIGN: Cross-sectional analysis of longitudinal studies, adjusting for repeated measures. SETTING: Not applicable. PATIENT(S): Women aged 30-45 years who had not undergone oophorectomy, hysterectomy, or natural menopause at the time of AMH measurement were included (n = 376 in the Michigan Bone Health and Metabolism Study and n = 321 in the Epidemiology of Interventions and Complications Study). Linear mixed regression was used to evaluate whether AMH concentrations differed by diabetes status, adjusting for repeated measurements of AMH within individual women, body mass index, smoking status, and oral contraceptive use. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Concentrations of AMH. RESULT(S): In unadjusted comparisons, women with and without diabetes had similar median AMH values before 35 years of age, although women with type 1 diabetes had a lower proportion of women with elevated AMH concentrations (≥5.0 ng/dL). After adjustment for covariates and multiple observations per woman, log AMH concentrations were significantly lower among women with type 1 diabetes compared with women without diabetes (β-coefficient -1.27, 95% confidence interval [-2.18, -0.36] in fully adjusted models) before 35 years of age. CONCLUSION(S): Before 35 years of age, women with type 1 diabetes have lower AMH levels than women without diabetes. Further investigation is needed to determine the etiologies of this difference and how it may contribute to reproductive disorders among women with type 1 diabetes.
OBJECTIVE: To compare concentrations of antimüllerian hormone (AMH) in women with and without type 1 diabetes. DESIGN: Cross-sectional analysis of longitudinal studies, adjusting for repeated measures. SETTING: Not applicable. PATIENT(S): Women aged 30-45 years who had not undergone oophorectomy, hysterectomy, or natural menopause at the time of AMH measurement were included (n = 376 in the Michigan Bone Health and Metabolism Study and n = 321 in the Epidemiology of Interventions and Complications Study). Linear mixed regression was used to evaluate whether AMH concentrations differed by diabetes status, adjusting for repeated measurements of AMH within individual women, body mass index, smoking status, and oral contraceptive use. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Concentrations of AMH. RESULT(S): In unadjusted comparisons, women with and without diabetes had similar median AMH values before 35 years of age, although women with type 1 diabetes had a lower proportion of women with elevated AMH concentrations (≥5.0 ng/dL). After adjustment for covariates and multiple observations per woman, log AMH concentrations were significantly lower among women with type 1 diabetes compared with women without diabetes (β-coefficient -1.27, 95% confidence interval [-2.18, -0.36] in fully adjusted models) before 35 years of age. CONCLUSION(S): Before 35 years of age, women with type 1 diabetes have lower AMH levels than women without diabetes. Further investigation is needed to determine the etiologies of this difference and how it may contribute to reproductive disorders among women with type 1 diabetes.
Authors: S L Broer; M J C Eijkemans; G J Scheffer; I A J van Rooij; A de Vet; A P N Themmen; J S E Laven; F H de Jong; E R Te Velde; B C Fauser; F J M Broekmans Journal: J Clin Endocrinol Metab Date: 2011-05-25 Impact factor: 5.958
Authors: C Tatone; M C Carbone; G Campanella; C Festuccia; P G Artini; V Talesa; R Focarelli; F Amicarelli Journal: J Biol Regul Homeost Agents Date: 2010 Jan-Mar Impact factor: 1.711
Authors: Ellen W Freeman; Clarisa R Gracia; Mary D Sammel; Hui Lin; Lony Chong-Leong Lim; Jerome F Strauss Journal: Fertil Steril Date: 2006-11-15 Impact factor: 7.329
Authors: Kristina W Whitworth; Donna D Baird; Anne Z Steiner; Riana M S Bornman; Gregory S Travlos; Ralph E Wilson; Matthew P Longnecker Journal: Epidemiology Date: 2015-05 Impact factor: 4.822
Authors: C Kim; R S Miller; B H Braffett; Y Pan; V L Arends; A K Saenger; A Barnie; A V Sarma Journal: Clin Endocrinol (Oxf) Date: 2018-01-26 Impact factor: 3.478
Authors: Catherine Kim; Yuanyuan Pan; Barbara H Braffett; Valerie L Arends; Michael W Steffes; Hunter Wessells; Aruna V Sarma Journal: Womens Midlife Health Date: 2017-08-18
Authors: Marek Gowkielewicz; Aleksandra Lipka; Marta Majewska; Aleksandra Piotrowska; Marta Szadurska-Noga; Jacek J Nowakowski; Marta Wiszpolska; Piotr Dzięgiel; Tomasz Wasniewski; Mariusz Krzysztof Majewski; Marcin Jozwik Journal: Cells Date: 2020-10-17 Impact factor: 6.600